Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
In Stock - Our Popular Transfer Sticks
19 May 2026 -
Microbial Risk in Bottled Water - Webinar
18 May 2026
MICROBIOLOGY EVENTS
-
Rapid and Alternative Micro Methods: From Sterility to AI Applications
21 May 2026 -
Microbial Risk in Bottled Water - Webinar
27 May 2026 -
Future Labs Live 2026
27 May 2026 -
Food Pathogen Testing: Unlock the Secrets to Successful Accreditation - Webinar
27 May 2026 -
From Hands-On to High-Tech: A Practical Roadmap for Implementing AI in Pharma QC
27 May 2026 -
FDA List of Potential Hazards in Foods
28 May 2026 -
APAS® Independence Discovery Day
3 Jun 2026 -
Endotoxin Testing in Radiopharmaceutical Drugs Production
3 Jun 2026 -
ASM Microbe 2026
4 Jun 2026 -
Rapid Methods Europe (RME) 2026
8 Jun 2026